Year: 2023
Type: editorial
Abstract: A survival rate of 82% and a disease control rate of 64% were reported in 11 subjects with advanced metastatic breast cancer enrolled in a Phase 2 trial testing a combination of cell vaccine Bria-I...
Authors: Ronald Ellis, Adam Weiss
Institution: Taylor and Francis (United Kingdom)
Language: English
Subfield: Immunology
Field: Immunology and Microbiology
Domain: Life Sciences
Open Access status: gold
Estimated APC paid: $3,175
OpenAlex ID: W4362457979